SYDNEY, March 29, 2022 /PRNewswire/ -- Medical device company Baymatob has completed a placement of A$4.215 million, with proceeds used to continue in-human clinical trials for its AI-guided labor monitoring device, Oli.

Cornerstoned by Australian Unity's Future of Healthcare Fund, the placement was strongly supported by institutional and high net...